Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (1) Edes, Inan Dr. (1) Kammertöns, Thomas Dr. (1) Kobelt, Dennis Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Rajewsky, Klaus Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (6) Wollert-Wulf, Brigitte (2) (-) Beule, Dieter Dr. (1) (-) Blüthgen, Nils (1) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (6) (-) Leisegang, Matthias Dr. (4) (-) Biologie maligner Lymphome (6) Epigenetische Regulation und Chromatinstruktur (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) Molekulare Immunologie und Gentherapie (1) (-) Molekulare Zellbiologie und Gentherapie (7) Myologie (1) Proteom Dynamik (6) RNA Biologie und Posttranscriptionale Regulation (1) Translationale Onkologie solider Tumore (1) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (7) 2007 (2) 2008 (4) 2009 (3) 2010 (7) 2011 (5) (-) 2012 (5) 2013 (2) 2014 (4) 2015 (6) 2016 (4) 2017 (7) 2018 (2) 2019 (1) 2020 (4) 2021 (3) 2022 (6) 12 Ergebnisse: Active Filter: Beule, Dieter Dr.Blüthgen, NilsDaniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Dr.Biologie maligner LymphomeMolekulare Zellbiologie und Gentherapie20062012 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2012 in Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky 01. Oktober 2012 in J Virol Protective capacity of virus-specific T cell receptor (TCR)-transduced CD8 T cells in vivo K. Mueller A. von Maessenhausen U. Aichele L. Staerck M. Leisegang W. Uckert H. Pircher 01. August 2012 in Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas 15. Juli 2012 in J Immunol Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition S. Wilde D. Sommermeyer M. Leisegang B. Frankenberger B. Mosetter W. Uckert D.J. Schendel 12. April 2012 in Blood TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo S. Spranger I. Jeremias S. Wilde M. Leisegang L. Staerck B. Mosetter W. Uckert M.H.M. Heemskerk D.J. Schendel B. Frankenberger 01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 05. Februar 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2012 in Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky
01. Oktober 2012 in J Virol Protective capacity of virus-specific T cell receptor (TCR)-transduced CD8 T cells in vivo K. Mueller A. von Maessenhausen U. Aichele L. Staerck M. Leisegang W. Uckert H. Pircher
01. August 2012 in Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas
15. Juli 2012 in J Immunol Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition S. Wilde D. Sommermeyer M. Leisegang B. Frankenberger B. Mosetter W. Uckert D.J. Schendel
12. April 2012 in Blood TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo S. Spranger I. Jeremias S. Wilde M. Leisegang L. Staerck B. Mosetter W. Uckert M.H.M. Heemskerk D.J. Schendel B. Frankenberger
01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
05. Februar 2006 in Virology Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein E. Kieback M. Mueller
